GB1161414A - Vaccines against Measles and process for their manufacture - Google Patents
Vaccines against Measles and process for their manufactureInfo
- Publication number
- GB1161414A GB1161414A GB38126/66A GB3812666A GB1161414A GB 1161414 A GB1161414 A GB 1161414A GB 38126/66 A GB38126/66 A GB 38126/66A GB 3812666 A GB3812666 A GB 3812666A GB 1161414 A GB1161414 A GB 1161414A
- Authority
- GB
- United Kingdom
- Prior art keywords
- vaccine
- measles
- virus
- vaccines
- aug
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
- 229960005486 vaccine Drugs 0.000 title abstract 4
- 201000005505 Measles Diseases 0.000 title abstract 2
- 238000004519 manufacturing process Methods 0.000 title 1
- 238000000034 method Methods 0.000 title 1
- 229940041323 measles vaccine Drugs 0.000 abstract 4
- WSFSSNUMVMOOMR-UHFFFAOYSA-N Formaldehyde Chemical compound O=C WSFSSNUMVMOOMR-UHFFFAOYSA-N 0.000 abstract 3
- 241000700605 Viruses Species 0.000 abstract 3
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 abstract 2
- 210000004027 cell Anatomy 0.000 abstract 2
- 210000001519 tissue Anatomy 0.000 abstract 2
- 241000282693 Cercopithecidae Species 0.000 abstract 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 abstract 1
- VGGSQFUCUMXWEO-UHFFFAOYSA-N Ethene Chemical compound C=C VGGSQFUCUMXWEO-UHFFFAOYSA-N 0.000 abstract 1
- 239000005977 Ethylene Substances 0.000 abstract 1
- 201000005702 Pertussis Diseases 0.000 abstract 1
- 208000000474 Poliomyelitis Diseases 0.000 abstract 1
- 241000288906 Primates Species 0.000 abstract 1
- 206010043376 Tetanus Diseases 0.000 abstract 1
- 239000002671 adjuvant Substances 0.000 abstract 1
- WNROFYMDJYEPJX-UHFFFAOYSA-K aluminium hydroxide Chemical compound [OH-].[OH-].[OH-].[Al+3] WNROFYMDJYEPJX-UHFFFAOYSA-K 0.000 abstract 1
- 229910021502 aluminium hydroxide Inorganic materials 0.000 abstract 1
- 229940001007 aluminium phosphate Drugs 0.000 abstract 1
- 229910000147 aluminium phosphate Inorganic materials 0.000 abstract 1
- 239000000427 antigen Substances 0.000 abstract 1
- 102000036639 antigens Human genes 0.000 abstract 1
- 108091007433 antigens Proteins 0.000 abstract 1
- 238000004113 cell culture Methods 0.000 abstract 1
- 210000001136 chorion Anatomy 0.000 abstract 1
- 210000001840 diploid cell Anatomy 0.000 abstract 1
- 150000002170 ethers Chemical class 0.000 abstract 1
- 239000000194 fatty acid Substances 0.000 abstract 1
- 210000002216 heart Anatomy 0.000 abstract 1
- 230000002779 inactivation Effects 0.000 abstract 1
- 210000001161 mammalian embryo Anatomy 0.000 abstract 1
- 210000003205 muscle Anatomy 0.000 abstract 1
- 239000002736 nonionic surfactant Substances 0.000 abstract 1
- 229960005030 other vaccine in atc Drugs 0.000 abstract 1
- 210000002741 palatine tonsil Anatomy 0.000 abstract 1
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 abstract 1
- 239000010452 phosphate Substances 0.000 abstract 1
- 229920000151 polyglycol Polymers 0.000 abstract 1
- 239000010695 polyglycol Substances 0.000 abstract 1
- 239000000244 polyoxyethylene sorbitan monooleate Substances 0.000 abstract 1
- 235000010482 polyoxyethylene sorbitan monooleate Nutrition 0.000 abstract 1
- 210000003491 skin Anatomy 0.000 abstract 1
- FHHPUSMSKHSNKW-SMOYURAASA-M sodium deoxycholate Chemical compound [Na+].C([C@H]1CC2)[C@H](O)CC[C@]1(C)[C@@H]1[C@@H]2[C@@H]2CC[C@H]([C@@H](CCC([O-])=O)C)[C@@]2(C)[C@@H](O)C1 FHHPUSMSKHSNKW-SMOYURAASA-M 0.000 abstract 1
- 210000000952 spleen Anatomy 0.000 abstract 1
- 239000004094 surface-active agent Substances 0.000 abstract 1
- 210000001550 testis Anatomy 0.000 abstract 1
- 210000001685 thyroid gland Anatomy 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/099—Bordetella
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A61K39/155—Paramyxoviridae, e.g. parainfluenza virus
- A61K39/165—Mumps or measles virus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/525—Virus
- A61K2039/5252—Virus inactivated (killed)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55505—Inorganic adjuvants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/70—Multivalent vaccine
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/18011—Paramyxoviridae
- C12N2760/18411—Morbillivirus, e.g. Measles virus, canine distemper
- C12N2760/18434—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/18011—Paramyxoviridae
- C12N2760/18411—Morbillivirus, e.g. Measles virus, canine distemper
- C12N2760/18451—Methods of production or purification of viral material
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Virology (AREA)
- General Health & Medical Sciences (AREA)
- Immunology (AREA)
- Medicinal Chemistry (AREA)
- Microbiology (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Mycology (AREA)
- Animal Behavior & Ethology (AREA)
- Zoology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- Genetics & Genomics (AREA)
- Wood Science & Technology (AREA)
- Biotechnology (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Communicable Diseases (AREA)
- Pulmonology (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DEB83486A DE1247548B (de) | 1965-08-28 | 1965-08-28 | Verfahren zur Herstellung einer Masern-Vaccine |
Publications (1)
Publication Number | Publication Date |
---|---|
GB1161414A true GB1161414A (en) | 1969-08-13 |
Family
ID=6981993
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GB38126/66A Expired GB1161414A (en) | 1965-08-28 | 1966-08-25 | Vaccines against Measles and process for their manufacture |
Country Status (9)
Country | Link |
---|---|
AT (1) | AT281280B (enrdf_load_stackoverflow) |
BE (1) | BE686101A (enrdf_load_stackoverflow) |
BR (1) | BR6682416D0 (enrdf_load_stackoverflow) |
CH (1) | CH484277A (enrdf_load_stackoverflow) |
DE (1) | DE1247548B (enrdf_load_stackoverflow) |
DK (2) | DK119938B (enrdf_load_stackoverflow) |
FR (2) | FR1502631A (enrdf_load_stackoverflow) |
GB (1) | GB1161414A (enrdf_load_stackoverflow) |
NL (1) | NL6611851A (enrdf_load_stackoverflow) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4211843A (en) * | 1977-11-30 | 1980-07-08 | L'institut Armand-Frappier | Strain of measles virus and process of producing the same |
CN104498446A (zh) * | 2014-12-15 | 2015-04-08 | 北京科兴生物制品有限公司 | 一种在疫苗生产中灭活病毒的方法 |
-
1965
- 1965-08-28 DE DEB83486A patent/DE1247548B/de active Pending
- 1965-12-10 FR FR41780A patent/FR1502631A/fr not_active Expired
-
1966
- 1966-03-09 FR FR52754A patent/FR5666M/fr not_active Expired
- 1966-08-23 NL NL6611851A patent/NL6611851A/xx unknown
- 1966-08-25 GB GB38126/66A patent/GB1161414A/en not_active Expired
- 1966-08-25 CH CH1232166A patent/CH484277A/de not_active IP Right Cessation
- 1966-08-26 AT AT812866A patent/AT281280B/de not_active IP Right Cessation
- 1966-08-26 BR BR182416/66A patent/BR6682416D0/pt unknown
- 1966-08-29 DK DK440366AA patent/DK119938B/da unknown
- 1966-08-29 BE BE686101D patent/BE686101A/xx unknown
-
1969
- 1969-11-14 DK DK605569AA patent/DK121811B/da unknown
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4211843A (en) * | 1977-11-30 | 1980-07-08 | L'institut Armand-Frappier | Strain of measles virus and process of producing the same |
CN104498446A (zh) * | 2014-12-15 | 2015-04-08 | 北京科兴生物制品有限公司 | 一种在疫苗生产中灭活病毒的方法 |
CN104498446B (zh) * | 2014-12-15 | 2017-03-15 | 北京科兴生物制品有限公司 | 一种在疫苗生产中灭活病毒的方法 |
Also Published As
Publication number | Publication date |
---|---|
BR6682416D0 (pt) | 1973-12-04 |
DK121811B (da) | 1971-12-06 |
AT281280B (de) | 1970-05-11 |
NL6611851A (enrdf_load_stackoverflow) | 1967-03-01 |
FR1502631A (fr) | 1967-11-24 |
CH484277A (de) | 1970-01-15 |
FR5666M (enrdf_load_stackoverflow) | 1968-01-02 |
DE1247548B (de) | 1967-08-17 |
BE686101A (enrdf_load_stackoverflow) | 1967-02-28 |
DK119938B (da) | 1971-03-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Kapsenberg | Possible antigenic relationship between varicella/zoster virus and herpes simplex virus | |
US3520972A (en) | Feline virus vaccines obtained by propagation and serial passage attenuation of virulent feline viruses in diploid feline embryo tissue cell serial passage subculture strains | |
US3959466A (en) | Highly attenuated cytomegalovirus vaccine and production thereof | |
Magill et al. | Studies with human influenza virus cultivated in artificial medium | |
GB1522006A (en) | Feline calicivirus vaccine and a process for the production thereof | |
GB1570732A (en) | Equine rhinopneumonitis vaccine | |
Weiss et al. | Growth of Rickettsia prowazeki in irradiated monolayer cultures of chick embryo entodermal cells | |
GB1161414A (en) | Vaccines against Measles and process for their manufacture | |
Morgan et al. | Latent viral infection of cells in tissue culture: IV. Latent infection of L cells with psittacosis virus | |
SE8201768L (sv) | Nytt vaccin | |
Furman et al. | Candida ciferrii and Candida chiropterorum isolated from clinical specimens | |
GB1604003A (en) | Process for the cultivation of viruses | |
Loebenstein | Native protein, an immunizing agent against virus infection | |
US4112068A (en) | Canine lung cell strain culture systems and processes for the cultivation of viruses and vaccines therefrom | |
DE2041647A1 (de) | Zellreihe aus der Leber menschlicher Embryonen,Verfahren zu deren Herstellung und deren Verwendung | |
SATO et al. | Cellular Basis of Immunity. II Inhibition of the Intracellular Multiplication of Salmonella enteritidis in Mouse Phagocytes of the Liver and Subscutaneous Tissue Immunized with Live Vaccine | |
Churchill | Intranuclear inclusions produced by bovine para-influenza | |
Matumoto et al. | Behavior of bovine ephemeral fever virus in laboratory animals and cell cultures | |
GB1133958A (en) | Process for the manufacture of a distemper vaccine | |
US3725542A (en) | Intramuscular vaccination program and vaccine against rhinopneumonitis and process for preparing it | |
Franklin et al. | CULTIVATION OF POLIOMYELITIS VIRUS IN TISSUE CULTURE IV. FURTHER OBSERVATIONS ON VIRUS PROPAGATION IN HUMAN TISSUES WITH A SYNTHETIC NUTRIENT MEDIUM | |
US3843451A (en) | Microorganism production | |
Rockwell et al. | Carbon dioxide as a factor in the growth of the tubercle bacillus and of other acidfast organisms | |
GB1358321A (en) | Method od tissue cell culture | |
Hotta | Some immunological properties of dengue virus cultivated in tissue culture |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PS | Patent sealed [section 19, patents act 1949] | ||
PCNP | Patent ceased through non-payment of renewal fee |